The FutureList – Step into the Future

logo-futurelist

Insights

Coverage of top innovators and technology trends from across The FutureList community

Innovation Memo with Yemaachi Biotech: Exploring their Groundbreaking Biotechnology

Yemaachi Biotech is a groundbreaking biotechnology company founded in 2020 in Accra, Ghana. They are rewriting the narrative of precision oncology by harnessing the triad of immunogenomics, bioinformatics, and artificial intelligence. Yemaachi is at the forefront of developing strategies for cancer detection and cure using data across Africa.

In today’s edition of our Innovation Memo, we profile Yemaachi Biotech, with CEO and Co-founder, Yaw Bediako, PhD.

Yaw Bediako, PhD is an accomplished researcher with experience working at renowned institutions like the Francis Crick Institute and Northwestern University, where he obtained his Ph.D. in Microbiology and Immunology. Yaw’s expertise lies in immunology, particularly in understanding the immune responses to infectious and non-communicable diseases.

Our Innovation Memos provide a comprehensive profile of an innovator, whether it’s a startup, hub, investor or more established corporate, highlighting technological and business model innovations. The Memo is written in direct consultation with a verified representative from that entity and also outlines suggestions around how to rapidly scale their innovation further through the use of The FutureList’s network.

If you’d like our team to profile your innovative company, please contact us at [email protected]. Get innovation insights from The FutureList weekly. Subscribe to our newsletter here